{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "9131061",
  "DateCompleted": {
    "Year": "1997",
    "Month": "05",
    "Day": "16"
  },
  "DateRevised": {
    "Year": "2013",
    "Month": "11",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "ger"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0720-4299",
      "JournalIssue": {
        "Volume": "62",
        "Issue": "5 Suppl",
        "PubDate": {
          "Year": "1994",
          "Month": "May"
        }
      },
      "Title": "Fortschritte der Neurologie-Psychiatrie",
      "ISOAbbreviation": "Fortschr Neurol Psychiatr"
    },
    "ArticleTitle": "[Risperdal: a new hope for schizophrenic patients?].",
    "Pagination": {
      "StartPage": "1",
      "EndPage": "4",
      "MedlinePgn": "1-4"
    },
    "PublicationTypeList": [
      "Journal Article"
    ],
    "VernacularTitle": "Risperdal: Eine neue Hoffnung f\u00fcr Schizophrene?"
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "Fortschr Neurol Psychiatr",
    "NlmUniqueID": "8103137",
    "ISSNLinking": "0720-4299"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Anxiety Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antipsychotic Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Serotonin Antagonists"
    },
    {
      "RegistryNumber": "145TFV465S",
      "NameOfSubstance": "Ritanserin"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Anxiety Agents"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antipsychotic Agents"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology",
        "psychology"
      ],
      "DescriptorName": "Anxiety"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Ritanserin"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy"
      ],
      "DescriptorName": "Schizophrenia"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Serotonin Antagonists"
    }
  ]
}